Coloplast A/S / Fundamentals

    Income statement

    Net revenue
    €3.73B
    Cost of goods sold
    €1.21B
    Gross profit
    €2.52B
    SG&A expenses
    €1.39B
    R&D expenses
    €122.65M
    EBITDA
    €1.18B
    D&A
    €180.76M
    EBIT
    €1.01B
    Interest expenses
    €166.70M
    EBT
    €830.83M
    Tax expenses
    €285.20M
    Net income
    €545.63M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€22.23M
    Changes in working capital
    -€100.82M
    Operating cash flow
    €860.69M
    Capex
    €191.21M
    Other investing cash flow
    -€17.94M
    Net investing cash flow
    -€173.13M
    Total cash dividends paid
    -€663.86M
    Issuance of common stock
    €37.09M
    Debt repayment
    -€36.69M
    Other financing cash flow
    -€38.70M
    Net financing cash flow
    -€702.16M
    Foreign exchange effects
    -€5.09M
    Net change in cash
    -€21.56M
    Cash at end of period
    €97.21M
    Free cash flow
    €1.05B

    Balance sheet

    Cash and cash equivalents
    €97.21M
    Cash and short-term investments
    €97.21M
    Total receivables
    €713.94M
    Inventory
    €505.73M
    Other current assets
    €96.54M
    Total current assets
    €1.41B
    Property, plant & equipment
    €915.86M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €16.07M
    Other non-current assets
    €0.00
    Total non-current assets
    €5.00B
    Total assets
    €6.41B
    Accounts payable
    €158.80M
    Short-term debt
    €929.11M
    Other current liabilities
    €143.81M
    Total current liabilities
    €1.41B
    Long-term debt
    €2.31B
    Deferred tax liabilities
    €349.34M
    Other non-current liabilities
    €133.09M
    Total non-current liabilities
    €2.80B
    Total liabilities
    €4.21B
    Common stock
    €30.53M
    Retained earnings
    €2.25B
    Other equity
    -€79.40M
    Total equity
    €2.20B
    Total liabilities and shareholders' equity
    €6.41B

    Company information

    Market capitalization
    €18.20B
    Employees
    17K
    Enterprise Value
    €166.73B

    Company ratios

    Gross margin
    67.5% Better than peer group: 47.9%
    EBITDA margin
    31.6% Much better than peer group: -6.0%
    EBIT margin
    27.1% Much better than peer group: -6.9%
    EBT margin
    22.3% Much better than peer group: 1.2%
    Net margin
    14.6% Much better than peer group: -11.7%
    ROE
    24.8% Much better than peer group: -10.4%
    ROA
    8.5% Better than peer group: 0.9%
    Asset turnover
    58.2% Much worse than peer group: 158.0%
    FCF margin
    17.9% Much better than peer group: -10.0%
    FCF yield
    3.7%
    Efficiency ratio
    68.4%
    Net sales per employee
    €222.89K
    Net income per employee
    €32.59K

    Notifications